THE EFFECT OF ULTRAFILTERED DIALYSATE ON THE CELLULAR CONTENT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN PATIENTS ON CHRONIC-HEMODIALYSIS

被引:78
作者
SCHINDLER, R [1 ]
LONNEMANN, G [1 ]
SCHAFFER, J [1 ]
SHALDON, S [1 ]
KOCH, KM [1 ]
KRAUTZIG, S [1 ]
机构
[1] UNIV NIMES HOSP,F-30006 NIMES,FRANCE
来源
NEPHRON | 1994年 / 68卷 / 02期
关键词
DIALYSATE ULTRAFILTRATION; IL-1; RA; INFLAMMATION;
D O I
10.1159/000188262
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We investigated the effect of dialysate ultrafiltration on the content of IL-1 receptor antagonist (IL-1Ra) in mononuclear cells (PBMC) as a marker of the inflammatory response. 11 patients on Cuprophan dialyzers were randomly assigned to treatment with standard bicarbonate dialysate first and then to ultrafiltered dialysate or the reverse order in a crossover design. In each treatment period (at least 4 weeks) weekly separations of PBMC were performed before the start of dialysis. Cellular content of IL-1Ra was determined in PBMC that were frozen immediately after separation; all values of IL-1Ra in each treatment period were averaged. The dialysate contained a median of 148 (range, 61-400) colony-forming units without dialysate filter; no bacterial growth was detected in ultrafiltered dialysate. The median endotoxin content was 80 pg/ml in nonfiltered dialysate; endotoxin was below 5 pg/ml in ah ultrafiltered dialysate samples. Cellular content of IL-1Ra decreased in all but 1 patient with the use of ultrafiltered dialysate (mean+/-SEM: 1,467+/-113 pg/ml without dialysate filter vs. 1,166+/-104 pg/ml with filter, p = 0.016). The present study demonstrates that the bacterial contamination of the dialysate induces a systemic inflammatory response in hemodialysis patients.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 27 条
[1]   LIPOPOLYSACCHARIDE INDUCES HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1 PRODUCTION IN THE SAME CELL [J].
ANDERSSON, J ;
BJORK, L ;
DINARELLO, CA ;
TOWBIN, H ;
ANDERSSON, U .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) :2617-2623
[2]  
BEMELMANS MHA, 1993, J IMMUNOL, V150, P2007
[3]   HUMAN INTERLEUKIN-1 PRODUCTION DURING HEMODIALYSIS [J].
BINGEL, M ;
LONNEMANN, G ;
SHALDON, S ;
KOCH, KM ;
DINARELLO, CA .
NEPHRON, 1986, 43 (03) :161-163
[4]   TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1 AND BETA 2-MICROGLOBULIN LEVELS IN CHRONIC-HEMODIALYSIS PATIENTS [J].
CARUANA, RJ ;
LOBEL, SA ;
LEFFELL, MS ;
CAMPBELL, H ;
CHEEK, PL .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1990, 13 (12) :794-798
[5]  
CHOLLETMARTIN S, 1991, CLIN EXP IMMUNOL, V83, P329
[6]  
DESCAMPSLATSCHA B, 1993, AM SOC NEPHROL, V4, P343
[7]   ULTRAFILTRATION TO REJECT HUMAN INTERLEUKIN-1-INDUCING SUBSTANCES DERIVED FROM BACTERIAL CULTURES [J].
DINARELLO, CA ;
LONNEMANN, G ;
MAXWELL, R ;
SHALDON, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (07) :1233-1238
[8]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[9]   MEASUREMENT OF IMMUNOREACTIVE INTERLEUKIN-1-BETA FROM HUMAN MONONUCLEAR-CELLS - OPTIMIZATION OF RECOVERY, INTRASUBJECT CONSISTENCY, AND COMPARISON WITH INTERLEUKIN-1-ALPHA AND TUMOR NECROSIS FACTOR [J].
ENDRES, S ;
GHORBANI, R ;
LONNEMANN, G ;
VANDERMEER, JWM ;
DINARELLO, CA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (03) :424-438
[10]   PRODUCTION OF INTERLEUKIN-1-RECEPTOR ANTAGONIST DURING EXPERIMENTAL ENDOTOXEMIA [J].
GRANOWITZ, EV ;
SANTOS, AA ;
POUTSIAKA, DD ;
CANNON, JG ;
WILMORE, DW ;
WOLFF, SM ;
DINARELLO, CA .
LANCET, 1991, 338 (8780) :1423-1424